Defects in calcium homeostasis and mitochondria can be reversed in Pompe disease
- PMID: 25758767
- PMCID: PMC4502791
- DOI: 10.1080/15548627.2015.1009779
Defects in calcium homeostasis and mitochondria can be reversed in Pompe disease
Abstract
Mitochondria-induced oxidative stress and flawed autophagy are common features of neurodegenerative and lysosomal storage diseases (LSDs). Although defective autophagy is particularly prominent in Pompe disease, mitochondrial function has escaped examination in this typical LSD. We have found multiple mitochondrial defects in mouse and human models of Pompe disease, a life-threatening cardiac and skeletal muscle myopathy: a profound dysregulation of Ca(2+) homeostasis, mitochondrial Ca(2+) overload, an increase in reactive oxygen species, a decrease in mitochondrial membrane potential, an increase in caspase-independent apoptosis, as well as a decreased oxygen consumption and ATP production of mitochondria. In addition, gene expression studies revealed a striking upregulation of the β 1 subunit of L-type Ca(2+) channel in Pompe muscle cells. This study provides strong evidence that disturbance of Ca(2+) homeostasis and mitochondrial abnormalities in Pompe disease represent early changes in a complex pathogenetic cascade leading from a deficiency of a single lysosomal enzyme to severe and hard-to-treat autophagic myopathy. Remarkably, L-type Ca(2+)channel blockers, commonly used to treat other maladies, reversed these defects, indicating that a similar approach can be beneficial to the plethora of lysosomal and neurodegenerative disorders.
Keywords: AIFM1, apoptosis-inducing factor, mitochondrion-associated, 1; CCCP, carbonyl cyanide m-chlorophenylhydrazone; DMEM, Dulbecco's modified Eagle's medium; EGTA, ethylene glycol-bis(2-aminoethylether)-N, N, N′, N′-tetraacetic acid; ERT, enzyme replacement therapy; GAA, glucosidase; GFP, green fluorescent protein; LAMP1, lysosomal-associated membrane protein 1; LSD, lysosomal storage disease; MAP1LC3A/B (LC3), microtubule-associated protein 1 light chain 3 α/β; MOPS, 3-morpholinopropane-1-sulfonic acid; MitoG, MitoTracker Green; OMM, outer mitochondrial membrane; Pompe disease; RFP, red fluorescent protein; ROS, reactive oxygen species; TUNEL, terminal deoxynucleotidyl transferase dUTP nick end labeling; Ub, ubiquitinated; VDCC, voltage-dependent Ca2+ channel; autophagy; calcium; lysosome; mitochondria; mitophagy; α, acid.
Figures
Similar articles
-
Mitophagy regulates mitochondrial network signaling, oxidative stress, and apoptosis during myoblast differentiation.Autophagy. 2019 Sep;15(9):1606-1619. doi: 10.1080/15548627.2019.1591672. Epub 2019 Apr 7. Autophagy. 2019. PMID: 30859901 Free PMC article.
-
Contractile activity attenuates autophagy suppression and reverses mitochondrial defects in skeletal muscle cells.Autophagy. 2018;14(11):1886-1897. doi: 10.1080/15548627.2018.1491488. Epub 2018 Aug 4. Autophagy. 2018. PMID: 30078345 Free PMC article.
-
Mitochondrial respiratory chain deficiency inhibits lysosomal hydrolysis.Autophagy. 2019 Sep;15(9):1572-1591. doi: 10.1080/15548627.2019.1586256. Epub 2019 Mar 27. Autophagy. 2019. PMID: 30917721 Free PMC article.
-
Autophagy and mitochondria in Pompe disease: nothing is so new as what has long been forgotten.Am J Med Genet C Semin Med Genet. 2012 Feb 15;160C(1):13-21. doi: 10.1002/ajmg.c.31317. Epub 2012 Jan 17. Am J Med Genet C Semin Med Genet. 2012. PMID: 22253254 Free PMC article. Review.
-
Failure of Autophagy in Pompe Disease.Biomolecules. 2024 May 13;14(5):573. doi: 10.3390/biom14050573. Biomolecules. 2024. PMID: 38785980 Free PMC article. Review.
Cited by
-
Analyzing immune cell infiltrates in skeletal muscle of infantile-onset Pompe disease using bioinformatics and machine learning.Sci Rep. 2024 Nov 11;14(1):27485. doi: 10.1038/s41598-024-78634-6. Sci Rep. 2024. PMID: 39523364
-
The European reference network for metabolic diseases (MetabERN) clinical pathway recommendations for Pompe disease (acid maltase deficiency, glycogen storage disease type II).Orphanet J Rare Dis. 2024 Nov 1;19(1):408. doi: 10.1186/s13023-024-03373-w. Orphanet J Rare Dis. 2024. PMID: 39482698 Free PMC article. Review.
-
Mitochondrial Dysfunction in Glycogen Storage Disorders (GSDs).Biomolecules. 2024 Sep 1;14(9):1096. doi: 10.3390/biom14091096. Biomolecules. 2024. PMID: 39334863 Free PMC article. Review.
-
The Autophagic Activator GHF-201 Can Alleviate Pathology in a Mouse Model and in Patient Fibroblasts of Type III Glycogenosis.Biomolecules. 2024 Jul 24;14(8):893. doi: 10.3390/biom14080893. Biomolecules. 2024. PMID: 39199279 Free PMC article.
-
Key considerations for investigating and interpreting autophagy in skeletal muscle.Autophagy. 2024 Oct;20(10):2121-2132. doi: 10.1080/15548627.2024.2373676. Epub 2024 Jul 15. Autophagy. 2024. PMID: 39007805 Review.
References
-
- Nunnari J, Suomalainen A. Mitochondria: in sickness and in health. Cell 2012; 148:1145-59; PMID:22424226; http://dx.doi.org/10.1016/j.cell.2012.02.035 - DOI - PMC - PubMed
-
- Hoppins S, Nunnari J. Cell biology. mitochondrial dynamics and apoptosis–the ER connection. Science 2012; 337:1052-4; PMID:22936767; http://dx.doi.org/10.1126/science.1224709 - DOI - PubMed
-
- Youle RJ, van der Bliek AM. Mitochondrial fission, fusion, and stress. Science 2012; 337:1062-5; PMID:22936770; http://dx.doi.org/10.1126/science.1219855 - DOI - PMC - PubMed
-
- Klionsky DJ. Autophagy: from phenomenology to molecular understanding in less than a decade. Nat Rev Mol Cell Biol 2007; 8:931-7; PMID:1771235819029340 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous